Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart Failure

ClinicalTrials.gov ID: NCT01786512

Public ClinicalTrials.gov record NCT01786512. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 19, 2026, 11:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-blind, Randomized, Placebo-controlled, Multicenter, Dose Escalation Study to Select and Evaluate an Oral Modified Release Formulation of Omecamtiv Mecarbil in Subjects With Heart Failure and Left Ventricular Systolic Dysfunction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objectives of this study are (i) to select an oral modified release (MR) formulation and dose of omecamtiv mecarbil for chronic twice daily (BID) dosing in adults with heart failure and left ventricular systolic dysfunction and (ii) to characterize its pharmacokinetics (PK) over 20 weeks of treatment.

Study identification

NCT ID
NCT01786512
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Cytokinetics
Industry
Enrollment
544 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 26, 2013 (Actual)
Primary completion
Jul 22, 2015 (Actual)
Completion
Aug 19, 2015 (Actual)
Last update posted
Aug 12, 2021

2013 – 2015

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
37
Facility City State ZIP Site status
Research Site Mobile Alabama 36608 —
Research Site Costa Mesa California 92626 —
Research Site Fresno California 93721 —
Research Site Inglewood California 90301 —
Research Site La Jolla California 92037 —
Research Site Los Angeles California 90033 —
Research Site Thousand Oaks California 91360 —
Research Site Tustin California 92780 —
Research Site Danbury Connecticut 06810 —
Research Site Newark Delaware 19718 —
Research Site Atlantis Florida 33462 —
Research Site Aventura Florida 33180 —
Research Site Clearwater Florida 33756 —
Research Site Miami Florida 33136 —
Research Site Tampa Florida 33606 —
Research Site Atlanta Georgia 30322 —
Research Site Macon Georgia 31201 —
Research Site Chicago Illinois 60612 —
Research Site Auburn Maine 04210 —
Research Site Baltimore Maryland 21201 —
Research Site Detroit Michigan 48202 —
Research Site Petoskey Michigan 49770 —
Research Site Minneapolis Minnesota 55415 —
Research Site Minneapolis Minnesota 55417 —
Research Site St Louis Missouri 63110 —
Research Site Las Vegas Nevada 89128 —
Research Site Cortlandt Manor New York 10567 —
Research Site The Bronx New York 10467 —
Research Site Chapel Hill North Carolina 27599 —
Research Site Durham North Carolina 27705 —
Research Site Oklahoma City Oklahoma 73120 —
Research Site Portland Oregon 97239 —
Research Site Greenville South Carolina 29605 —
Research Site Nashville Tennessee 37232-8802 —
Research Site Tullahoma Tennessee 37388 —
Research Site Houston Texas 77030 —
Research Site Seattle Washington 98195 —
Research Site Madison Wisconsin 53792 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 63 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01786512, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 12, 2021 · Synced Oct 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01786512 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →